| CEO Name | Prahlad Singh |
| Nationality | India |
| Net Worth Estimation | $40 million |
Prahlad Singh's estimated net worth of around $40 million is primarily attributed to his compensation package as CEO of PerkinElmer, which includes salary, bonuses, stock awards, and accumulated equity holdings. His financial standing is further bolstered by long-term incentives, company performance, and vested shares acquired since joining leadership roles within the organization.
Prahlad Singh, CEO of PerkinElmer in the biotechnology sector, has an estimated net worth of $40 million, which is 50% of the $80 million maximum and 300% above the $10 million minimum. His net worth positions him in the mid-to-upper range among biotech CEOs.
Business Category: Biotechnology
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 80000000 USD
Prahlad Singh Performance in PerkinElmer
Prahlad Singh, CEO of PerkinElmer, demonstrates strategic leadership by driving innovation and operational excellence in diagnostics and life sciences. His decisive focus on expanding digital capabilities and global market presence has significantly enhanced company performance and shareholder value. Under Singh's leadership, PerkinElmer has seen accelerated growth, robust financial results, and strengthened its position as a leader in scientific instrumentation and services.
Latest News
PerkinElmer expands life sciences services and adjusts manufacturing footprint.
PerkinElmer, led by CEO Dirk Bontridder, acquired Project Farma to enhance its OneSource professional services for life sciences, emphasizing innovation in therapies. Concurrently, the company announced closing its Shelton, CT factory by April 2026, relocating manufacturing while retaining R&D roles locally.
Source: http://www.businesswire.com/news/home/20250311611290/en/PerkinElmer-Acquires-Project-Farma-Expanding-Its-OneSource-Professional-Services-Offering-for-the-Life-Sciences-Industry